Immunocore Holdings plc American Depositary Shares (IMCR) Stock Price, Quote & AI Analysis

Live IMCR stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Immunocore Holdings plc American Depositary Shares.

TradeVae provides AI-driven analysis and real-time market intelligence for Immunocore Holdings plc American Depositary Shares (IMCR), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

IMCR
Immunocore Holdings plc American Depositary Shares
real-time
$0.00 +0.00 (+0.00%)
Open
33.710000
High
34.280000
Low
33.520000
Volume
301,763
VWAP
-
Market Cap
$1,729,429,516.00
52W Range
$27.56 - $40.71
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Nov 4, 2026 Q3
Before Open
EPS Estimate: $-0.0131
Revenue Estimate: $115,948,500.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Immunocore Holdings plc American Depositary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Immunocore Holdings plc American Depositary Shares Overview

Company information

Company Overview

Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. the firm's lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.

Company Details
Market Cap
$1.81B
Shares Outstanding
53,292,801
Weighted Shares Outstanding
50,865,574
CEO
Bahija Jallal
Address
90 PARK DRIVE, OXFORDSHIRE, X0, OX14 4RY
Employees
524
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Immunocore Holdings plc American Depositary Shares Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...